INCOG BioPharma Services, a contract development and manufacturing organization (CDMO) specializing in sterile injectable biopharmaceuticals, is investing in a second 100,000-square-foot building on its campus—increasing its commercial-scale device assembly capacity in support of autoinjectors, pens, wearable injectors, and syringe accessorizing, while also adding new labeling and final packaging capabilities. The second building will further enable INCOG to offer comprehensive, end-to-end s...